Current Project Funding
National Natural Science Foundation of China (NSFC) Major Key Project, Innovative Research Group Project, Tissue and Organ Injury Repair and Regeneration [81921004; 10.5 million RMB; 2020/01-2024/12; PI: Deling Kong].
NSFC Key Project, Bioactive carrier material regulating stem cells and tissue microenvironment for the treatment of acute kidney injury [81830060, 2.94 million RMB, 2019/01-2023/12; PI: Deling Kong].
NKU Lateral Research Project, Surface functional construction of sustained-release nitric oxide blood-contact materials [150,000 RMB; 2020/01-2021/12, PI: Kai Wang].
NKU Transverse Research Project, Biomedical evaluation of new in vivo engineered blood vessels [500,000 RMB; 2019/04-2022/04; PI: Kai Wang].
NSFC Fellowship Fund for Young International Scientists, Multifunctional Nanoparticles for Diagnosis, Monitoring and Therapeutic Delivery in Chronic Kidney Disease (Renewal Fund) [82050410449; 270,000 RMB; 2021/01-2022/12; PI: Adam Midgley].
NSFC General Project, Study on the enhancement of the immunotherapeutic effect of mesenchymal stem cells by engineering culture conditions [31771066; 630,000 RMB; 2018/01-2021/12].
NSFC General Project, Construction and functional modification of hybrid artificial blood vessel materials composed of polymer melt-spun fibers and acellular matrix [81772000; 550,00 RMB; 2018/01-2021/12, PI: Kai Wang].
Cultivation Project for Major Research Programs in Regulatory Mechanisms of Vascular Homeostasis and Remodeling, Effect of Biomimetic Electrical Signalling Vascular Materials on the Regulation of Vascular Tissue Regeneration and Functional Homeostasis [91939112; 400,000 RMB; 2020/01-2021/12; PI: Kai Wang].
Completed Project Funding
Key Project of Tianjin Natural Science Foundation (Tianjin NSF), 18JCZDJC37600, Construction and Functional Modification of polymer Fiber Skeleton Enhanced Small-caliber artificial Blood vessel in Vivo, 2018.04-2021.03, 200,000 RMB, Principal investigator: Wang Kai.
National Key Research and Development Program project, Design, preparation, and engineering technology of new responsive intelligent hydrogel, 2017YFC1103500, 13.96 million RMB, 2017.07-2020.12. Person in charge: Kong Deling.
Funded by the National Natural Science Foundation of China, 81850410552H1819, Multifunctional Nanoparticles for Diagnosis, Monitoring and Therapeutic Delivery in Chronic Kidney Disease. [2019/01-2020/12; 400,000 RMB; PI: Adam Midgley].
Tianjin Science and Technology Support key project in 2016, to enhance the development of new products of vascularized bone repair materials, cooperation with Tianjin Saiing Biological Engineering Technology Co., LTD., 16YFZCSY01020, 300000 RMB, 2016.04-2019.03. Person in charge: Kong Deling.
The key project of the National Natural Science Foundation of China, the construction of bioactive small-caliber artificial blood vessels and the mechanism of inducing angiogenesis.Project approval Number: 81530059, project start and end date: January 2016 - December 2020.12, funds: RMB 3.26 million. Person in charge: Kong Deling.
National Key Basic Research and Development Program (973 Program), Basic and Frontier Research on new Topological Structures of molecular functional Carbon materials, 2015CB856500, 2015.1-2019.12. Person in charge: Kong Deling.
Innovation Team Support Program of The Ministry of Education, Cardiovascular Tissue Engineering, IRT13023, 2014-2016, 3 million. Person in charge: Kong Deling.
A bioactive artificial blood vessel in vivo degradation and regulation of angiogenesis, No.81401534, 2015.01-2017.12, Amount: 230,000 RMB. Person in charge: Wang Kai.
Tianjin Youth Project, structure design and functional modification: construction of new small-caliber artificial blood vessel, No.14JCQNJC13900, 2014.04-2017.12, amount: 60,000 RMB. Person in charge: Wang Kai.
Presided over the project of National Natural Science Foundation of China -- structural design and biological function evaluation of artificial vascular implant materials for autocatalytic NO in situ controlled release (51073081, 2011.1-2013.12); Person in charge: Kong Deling.
Project of Youth Science Foundation to study the improvement effect of Netrin-1 gene on bone marrow stem cell transplantation in the treatment of myocardial infarction, 81201207, 2013-2015, 230,000 RMB. Person in charge: Zhang Jun.
National Natural Science Foundation of China, key international (regional) cooperative research project, molecular imaging tracer stem cell transplantation for the treatment of myocardial infarction, 81220108015, 2013-2017; 3 million RMB.
Biological and pathological evaluation of endothelial stem cell capture in small-caliber artificial blood vessel Research, funded by the National Natural Science Foundation of China, 81171478, 2012-2015, RMB 600,000.
National 973 Program: A sub-project of the National Major Scientific Research Program on stem cells, Basic Research on Epigenetic Regulation of Stem cell differentiation and its Application in the Treatment of Diabetes, Imaging Evaluation of the biological function of pancreatic kidney stem/progenitor cells in vivo, project Approval Number: 2011CB964903, 2011-2015.Sub-project leader: Kong Deling.
The key project of National Natural Science Foundation of China, Structure Design and tissue regeneration of Small-caliber blood vessel Material, Project Approval No. : 50830104, 2009-2012, 2 million RMB.
National Science Foundation for Outstanding Youth, Biomaterials, No.30725030, 2008-2011, 2 million RMB.National Natural Science Funds for Distinguished Young Scholar.
National 973 Program: Tissue inducible biomedical Materials, subproject Design and Construction of Induced Anticoagulant biological Surface, No. 2005CB623904, 2005-2010, 2.23 million RMB, Subproject leader: Kong Deling.
Research on the Performance of self-assembled dendrimer Gene Delivery System, No.20774050, 2008-2010, 320,000 RMB, National Natural Science Foundation of China. Supported by National Natural Science Foundation of China; Supported by NSFC.
The project of National Natural Science Foundation of China, using SDF-1/CXCR4 interaction to improve the therapeutic effect of bone marrow stem cells on myocardial infarction, No. 30570471, 2006-2008, 320,000 RMB.
